Viatris Inc
Research Viatris Inc (VTRS) on Bullrun: market cap USD 19.32B, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVTRS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 19.32B
- Dividend yield2.8%
- Financial periodQ2 2026
- RevenueUSD 3.76B
- Net income-USD 118.80M
- Free cash flowUSD 322.00M
- Gross margin38.8%
Valuation Snapshot
latest market cap is USD 19.32B; dividend yield is 2.8%.
Peer valuation comparison
Latest dividend yield is 2.84% versus a Healthcare sector median of 2.11% (34.6% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 14.25B | -USD 3.51B | USD 1.94B | 35.2% | -3 | USD 1.32B | USD 14.41B | USD 14.71B |
| FY2024 | USD 14.69B | -USD 634.20M | USD 1.98B | 38.3% | -0.53 | USD 734.80M | USD 14.04B | USD 18.64B |
| FY2023 | USD 15.39B | USD 54.70M | USD 2.52B | 41.8% | 0.05 | USD 991.90M | USD 18.12B | USD 20.47B |
| FY2022 | USD 16.22B | USD 2.08B | USD 2.59B | 40.1% | 1.71 | USD 1.26B | USD 19.27B | USD 21.07B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 19.32B | n/a | 2.9% | 0.48 |
| 2025 | 2025-12-31 | USD 14.33B | n/a | 3.9% | 0.48 |
| 2024 | 2024-12-31 | USD 14.86B | n/a | 3.9% | 0.48 |
| 2023 | 2023-12-29 | USD 12.99B | 7.2 | 4.4% | 0.48 |
| 2022 | 2022-12-30 | USD 13.50B | 16.9 | 4.3% | 0.48 |
| 2021 | 2021-12-31 | USD 16.36B | n/a | 2.4% | 0.33 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.48 USD, yield 2.8%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.48 USD |
| FY2024 | 0.48 USD |
| FY2023 | 0.48 USD |
| FY2022 | 0.48 USD |
About Viatris Inc
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Viatris Inc's market cap?
Viatris Inc's market capitalization is USD 19.32B.
Does Viatris Inc pay a dividend?
Viatris Inc has a dividend yield of 2.8%.
What does Viatris Inc do?
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars.